Tom Kerr

Tom Kerr has worked in the financial services industry for over 25 years. Currently he is a Senior Investment Specialist at WestPac Wealth Partners in Missoula, MT. Prior to that he was Chief Investment Officer and Director of Research of SGL Investment Advisors. He was principal owner of Rocky Peak Capital Management where he managed the Rocky Peak Smallcap Value mutual fund. He was also a Portfolio Manager and Equity Analyst for a $4 billion investment firm in Los Angeles, CA. There he was the co-manager of the Smallcap Value strategy and RCB Smallcap Value Mutual Fund as well an Equity Analyst covering consumer products, business services, retail and media industries. At RCB he was instrumental in developing an innovative and original research process and investment philosophy for the firm. Prior to that he was a financial analyst at a large international bank as well as at one of the world’s largest corporations.


Mr. Kerr has also been a contributing writer to TheStreet.com, RagingBull.com and InvestorPlace.com. Mr. Kerr is a CFA charterholder and obtained a B.B.A in Finance from Texas Tech University. He serves on the boards of CASA of Missoula and the Montana State Parks Foundation. He is also a member of the Montana Snowbowl Volunteer Ski Patrol.

Recent Articles

Stop Thinking About Facebook as a Tech Stock, Because It’s Not

Investors have been wrong to think of Facebook as a tech stock. FB stock is a growth stock that will eventually get held back by advertising cyclicality.

Nokia’s Return to Blue-Chip Technology Status May Finally Happen

Nokia may be on track to sustainable growth with 5G as a tailwind. The financials for NOK stock are looking up after Q2 earnings.

Ashford Hospitality Trust Has a Long Road Back to Success

With a portfolio of over 100 hotels, Ashford Hospitality Trust was an interesting stock before the pandemic, but it's a gamble today.

Why Clean Energy Fuels Has Plenty of Work To Do

Absent a Reddit fueled mania, Clean Energy Fuels needs to start showing higher margins if CLNE stock doesn't want to fall behind.

Senseonics Financials Don’t Support Its Billion-Dollar-Plus Market Cap

Senseonics' revolutionary Eversense glucose monitor may be redefining diabetes treatment, but its current contribution doesn't justify SENS stock rich valuation.